ReP USP - Resultado da busca

Artigo de periodico
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia (2023)
Catto, Luiz Fernando Bazzo ; Zanelatto, Leonardo C.; Donaires, Flávia Sacilotto ; Carvalho, Vinícius Silva de; Santana, Bárbara Amélia Aparecida ; Pinto, André L.; Fantacini, Daianne; Souza, Lucas Eduardo Botelho de ; Fonseca, Natasha Peixoto ; Telho, Bruno S.; Madeira, Maria Isabel Ayrosa; Pagnano, Katia Borgia Barbosa; Firmato, Ana Beatriz; Fagundes, Evandro Maranhão; Higashi, Márcia; Nunes, Elenaide Coutinho; Traina, Fabiola ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Calado, Rodrigo Tocantins
Fonte: Blood Advances. Unidades: FMRP, FM
Assuntos: LINHAGEM CELULAR, LEUCEMIA MIELOIDE AGUDA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATTO, Luiz Fernando Bazzo et al. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Advances, v. 7, n. 22, p. 7067-7078, 2023Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2023010658. Acesso em: 13 maio 2024.
APA
Catto, L. F. B., Zanelatto, L. C., Donaires, F. S., Carvalho, V. S. de, Santana, B. A. A., Pinto, A. L., et al. (2023). Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Advances, 7( 22), 7067-7078. doi:10.1182/bloodadvances.2023010658
NLM
Catto LFB, Zanelatto LC, Donaires FS, Carvalho VS de, Santana BAA, Pinto AL, Fantacini D, Souza LEB de, Fonseca NP, Telho BS, Madeira MIA, Pagnano KBB, Firmato AB, Fagundes EM, Higashi M, Nunes EC, Traina F, Pontes LL de F, Rego EM, Calado RT. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia [Internet]. Blood Advances. 2023 ; 7( 22): 7067-7078.[citado 2024 maio 13 ] Available from: https://doi.org/10.1182/bloodadvances.2023010658
Vancouver
Catto LFB, Zanelatto LC, Donaires FS, Carvalho VS de, Santana BAA, Pinto AL, Fantacini D, Souza LEB de, Fonseca NP, Telho BS, Madeira MIA, Pagnano KBB, Firmato AB, Fagundes EM, Higashi M, Nunes EC, Traina F, Pontes LL de F, Rego EM, Calado RT. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia [Internet]. Blood Advances. 2023 ; 7( 22): 7067-7078.[citado 2024 maio 13 ] Available from: https://doi.org/10.1182/bloodadvances.2023010658
Artigo de periodico
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study (2022)
Parra, Rogério Serafim; Chebli, Júlio Maria Fonseca; Queiroz, Natália Sousa Freitas; Damião, Aderson Omar Mourão Cintra; Azevedo, Matheus Freitas Cardoso de; Chebli, Liliana Andrade; Bertges, Erika Ruback; Alves Junior, Antonio José Tiburcio; Ambrogini Junior, Orlando; Silva, Bianca Loyo Pona Schiavetti da; Lubini, Marcio; Bafutto, Mauro; Flores, Cristina; Vilela, Eduardo Garcia; Boratto, Sandra Felice; Gasparetti Júnior, Newton Luiz Tricarico; Steinwurz, Flavio; Carvalho, Nayara Salgado; Féres, Omar; Rocha, José Joaquim Ribeiro da
Fonte: BMC Gastroenterology. Unidades: FMRP, FM
Assuntos: DOENÇA DE CROHN, ENTEROPATIAS INFLAMATÓRIAS, INTESTINOS, TERAPIA BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Rogério Serafim et al. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology, v. 22, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12876-022-02280-3. Acesso em: 13 maio 2024.
APA
Parra, R. S., Chebli, J. M. F., Queiroz, N. S. F., Damião, A. O. M. C., Azevedo, M. F. C. de, Chebli, L. A., et al. (2022). Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology, 22. doi:10.1186/s12876-022-02280-3
NLM
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, Azevedo MFC de, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, Silva BLPS da, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Júnior NLT, Steinwurz F, Carvalho NS, Féres O, Rocha JJR da. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study [Internet]. BMC Gastroenterology. 2022 ; 22[citado 2024 maio 13 ] Available from: https://doi.org/10.1186/s12876-022-02280-3
Vancouver
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, Azevedo MFC de, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, Silva BLPS da, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Júnior NLT, Steinwurz F, Carvalho NS, Féres O, Rocha JJR da. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study [Internet]. BMC Gastroenterology. 2022 ; 22[citado 2024 maio 13 ] Available from: https://doi.org/10.1186/s12876-022-02280-3
Artigo de periodico
The Challenges in the follow-Up and treatment of Brazilian children with hereditary angioedema (2021)
Araújo-Simões, Joanna; Boanova, Aline Gisele Pena; Constantino-Silva, Rosemeire Navickas; Fragnan, Nyla Thyara Melo Lobão; Pinto, Jorge Andrade; Minafra, Fernanda G.; Moreno, Adriana Santos; Arruda, Luisa Karla de Paula; Roxo Junior, Pérsio; Ferriani, Mariana Paes Leme
Fonte: International Archives of Allergy and Immunology. Unidade: FMRP
Assuntos: ANAFILAXIA, ANGIOEDEMA, VIGILÂNCIA EPIDEMIOLÓGICA, SAÚDE PÚBLICA, QUALIDADE DE VIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO-SIMÕES, Joanna et al. The Challenges in the follow-Up and treatment of Brazilian children with hereditary angioedema. International Archives of Allergy and Immunology, v. 182, n. 7, p. 585-591, 2021Tradução . . Disponível em: https://doi.org/10.1159/000512944. Acesso em: 13 maio 2024.
APA
Araújo-Simões, J., Boanova, A. G. P., Constantino-Silva, R. N., Fragnan, N. T. M. L., Pinto, J. A., Minafra, F. G., et al. (2021). The Challenges in the follow-Up and treatment of Brazilian children with hereditary angioedema. International Archives of Allergy and Immunology, 182( 7), 585-591. doi:10.1159/000512944
NLM
Araújo-Simões J, Boanova AGP, Constantino-Silva RN, Fragnan NTML, Pinto JA, Minafra FG, Moreno AS, Arruda LK de P, Roxo Junior P, Ferriani MPL. The Challenges in the follow-Up and treatment of Brazilian children with hereditary angioedema [Internet]. International Archives of Allergy and Immunology. 2021 ; 182( 7): 585-591.[citado 2024 maio 13 ] Available from: https://doi.org/10.1159/000512944
Vancouver
Araújo-Simões J, Boanova AGP, Constantino-Silva RN, Fragnan NTML, Pinto JA, Minafra FG, Moreno AS, Arruda LK de P, Roxo Junior P, Ferriani MPL. The Challenges in the follow-Up and treatment of Brazilian children with hereditary angioedema [Internet]. International Archives of Allergy and Immunology. 2021 ; 182( 7): 585-591.[citado 2024 maio 13 ] Available from: https://doi.org/10.1159/000512944
Artigo de periodico
Hypertension: a new treatment for an old disease? Targeting the immune system (2019)
Bomfim, Gisele Facholi; Cau, Stefany Bruno Assis; Bruno, Alexandre Santos; Fedoce, Aline Garcia; Carneiro, Fernando Silva
Fonte: British Journal of Pharmacology. Unidade: FMRP
Assuntos: HIPERTENSÃO, FARMACOLOGIA, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOMFIM, Gisele Facholi et al. Hypertension: a new treatment for an old disease? Targeting the immune system. British Journal of Pharmacology, v. 176, n. 12, p. 2028-2048, 2019Tradução . . Disponível em: https://doi.org/10.1111/bph.14436. Acesso em: 13 maio 2024.
APA
Bomfim, G. F., Cau, S. B. A., Bruno, A. S., Fedoce, A. G., & Carneiro, F. S. (2019). Hypertension: a new treatment for an old disease? Targeting the immune system. British Journal of Pharmacology, 176( 12), 2028-2048. doi:10.1111/bph.14436
NLM
Bomfim GF, Cau SBA, Bruno AS, Fedoce AG, Carneiro FS. Hypertension: a new treatment for an old disease? Targeting the immune system [Internet]. British Journal of Pharmacology. 2019 ; 176( 12): 2028-2048.[citado 2024 maio 13 ] Available from: https://doi.org/10.1111/bph.14436
Vancouver
Bomfim GF, Cau SBA, Bruno AS, Fedoce AG, Carneiro FS. Hypertension: a new treatment for an old disease? Targeting the immune system [Internet]. British Journal of Pharmacology. 2019 ; 176( 12): 2028-2048.[citado 2024 maio 13 ] Available from: https://doi.org/10.1111/bph.14436
Artigo de periodico
Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) (2018)
Acquatella, Harry; Asch, Federico M.; Barbosa, Marcia M.; Barros, Marcio; Bern, Caryn; Cavalcante, Joao L.; Echeverria Correa, Luis Eduardo; Lima, Joao; Marcus, Rachel; Marin Neto, José Antonio; Migliore, Ricardo; Milei, Jose; Morillo, Carlos A.; Nunes, Maria Carmo Pereira; Vieira, Marcelo Luiz Campos; Viotti, Rodolfo
Fonte: Journal of the American Society of Echocardiography. Unidade: FMRP
Assuntos: DOENÇA DE CHAGAS, MIOCARDIOPATIA CONGESTIVA, ANEURISMA, VENTRÍCULO CARDÍACO, ECOCARDIOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ACQUATELLA, Harry et al. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC). Journal of the American Society of Echocardiography, v. 31, n. 1, p. 3-25, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.echo.2017.10.019. Acesso em: 13 maio 2024.
APA
Acquatella, H., Asch, F. M., Barbosa, M. M., Barros, M., Bern, C., Cavalcante, J. L., et al. (2018). Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC). Journal of the American Society of Echocardiography, 31( 1), 3-25. doi:10.1016/j.echo.2017.10.019
NLM
Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Vieira MLC, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) [Internet]. Journal of the American Society of Echocardiography. 2018 ; 31( 1): 3-25.[citado 2024 maio 13 ] Available from: https://doi.org/10.1016/j.echo.2017.10.019
Vancouver
Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Vieira MLC, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) [Internet]. Journal of the American Society of Echocardiography. 2018 ; 31( 1): 3-25.[citado 2024 maio 13 ] Available from: https://doi.org/10.1016/j.echo.2017.10.019
Trabalho de evento-resumo periodico
Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells (2017)
Machado Neto, João Agostinho ; Coelho-Silva, Juan Luiz; Lucena-Araujo, Antonio R.; Scheucher, Priscila Santos; Melo, Raul Antônio Morais; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia B. B; Fagundes, Evandro Maranhão; Chauffaille, Maria de Lourdes; Chiattone, Carlos; Rego, Eduardo Magalhães; Traina, Fabiola
Fonte: Blood. Nome do evento: Annual meeting and Exposition of American Society of Hematology (ASH). Unidades: ICB, FMRP
Assuntos: LEUCEMIA, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: http://www.bloodjournal.org/content/130/Suppl_1/2514. Acesso em: 13 maio 2024. , 2017
APA
Machado Neto, J. A., Coelho-Silva, J. L., Lucena-Araujo, A. R., Scheucher, P. S., Melo, R. A. M., Bittencourt, R., et al. (2017). Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de http://www.bloodjournal.org/content/130/Suppl_1/2514
NLM
Machado Neto JA, Coelho-Silva JL, Lucena-Araujo AR, Scheucher PS, Melo RAM, Bittencourt R, Pasquini R, Pagnano KBB, Fagundes EM, Chauffaille M de L, Chiattone C, Rego EM, Traina F. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells [Internet]. Blood. 2017 ; 130[citado 2024 maio 13 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/2514
Vancouver
Machado Neto JA, Coelho-Silva JL, Lucena-Araujo AR, Scheucher PS, Melo RAM, Bittencourt R, Pasquini R, Pagnano KBB, Fagundes EM, Chauffaille M de L, Chiattone C, Rego EM, Traina F. Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells [Internet]. Blood. 2017 ; 130[citado 2024 maio 13 ] Available from: http://www.bloodjournal.org/content/130/Suppl_1/2514
Artigo de periodico
Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients (2017)
Wowk, Pryscilla Fanini; Franco, Luis Henrique; Fonseca, Denise Morais da ; Paula, Marina Oliveira; Vianna, Élcio dos Santos Oliveira; Wendling, Ana Paula; Augusto, Valéria Maria; Elói-Santos, Silvana Maria; Teixeira-Carvalho, Andréa; Silva, Flávia Dias Coelho; Vinhas, Solange Alves; Martins Filho, Olindo Assis; Palaci, Moisés; Silva, Célio Lopes; Bonato, Vânia Luiza Deperon
Fonte: Human Vaccines & Immunotherapeutics. Unidades: ICB, FMRP
Assuntos: LINFÓCITOS T, IMUNOLOGIA CELULAR, INTERFERONS, MACRÓFAGOS, MYCOBACTERIUM TUBERCULOSIS, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WOWK, Pryscilla Fanini et al. Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients. Human Vaccines & Immunotherapeutics, v. 13, n. 5, p. 1040-1050, 2017Tradução . . Disponível em: https://doi.org/10.1080/21645515.2016.1264547. Acesso em: 13 maio 2024.
APA
Wowk, P. F., Franco, L. H., Fonseca, D. M. da, Paula, M. O., Vianna, É. dos S. O., Wendling, A. P., et al. (2017). Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients. Human Vaccines & Immunotherapeutics, 13( 5), 1040-1050. doi:10.1080/21645515.2016.1264547
NLM
Wowk PF, Franco LH, Fonseca DM da, Paula MO, Vianna É dos SO, Wendling AP, Augusto VM, Elói-Santos SM, Teixeira-Carvalho A, Silva FDC, Vinhas SA, Martins Filho OA, Palaci M, Silva CL, Bonato VLD. Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients [Internet]. Human Vaccines & Immunotherapeutics. 2017 ; 13( 5): 1040-1050.[citado 2024 maio 13 ] Available from: https://doi.org/10.1080/21645515.2016.1264547
Vancouver
Wowk PF, Franco LH, Fonseca DM da, Paula MO, Vianna É dos SO, Wendling AP, Augusto VM, Elói-Santos SM, Teixeira-Carvalho A, Silva FDC, Vinhas SA, Martins Filho OA, Palaci M, Silva CL, Bonato VLD. Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients [Internet]. Human Vaccines & Immunotherapeutics. 2017 ; 13( 5): 1040-1050.[citado 2024 maio 13 ] Available from: https://doi.org/10.1080/21645515.2016.1264547
Artigo de periodico
Altered natural killerr cell function in HIV-exposed uninfected infants (2017)
Smith, Christiana; Jalbert, Emilie; Almeida, Volia de; Canniff, Jennifer; Lenz, Laurel L.; Mussi-Pinhata, Marisa Márcia; Cohn, Rachel A.; Yu, Qilu; Amaral, Fabiana R.; Pinto, Jorge; Alarcon, Jorge O.; Siberry, George; Weinberg, Adriana
Fonte: Frontiers in Immunology. Unidade: FMRP
Assuntos: HIV, INTERLEUCINAS, DOENÇAS INFECCIOSAS, DOENÇAS RESPIRATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMITH, Christiana et al. Altered natural killerr cell function in HIV-exposed uninfected infants. Frontiers in Immunology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.00470. Acesso em: 13 maio 2024.
APA
Smith, C., Jalbert, E., Almeida, V. de, Canniff, J., Lenz, L. L., Mussi-Pinhata, M. M., et al. (2017). Altered natural killerr cell function in HIV-exposed uninfected infants. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.00470
NLM
Smith C, Jalbert E, Almeida V de, Canniff J, Lenz LL, Mussi-Pinhata MM, Cohn RA, Yu Q, Amaral FR, Pinto J, Alarcon JO, Siberry G, Weinberg A. Altered natural killerr cell function in HIV-exposed uninfected infants [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2024 maio 13 ] Available from: https://doi.org/10.3389/fimmu.2017.00470
Vancouver
Smith C, Jalbert E, Almeida V de, Canniff J, Lenz LL, Mussi-Pinhata MM, Cohn RA, Yu Q, Amaral FR, Pinto J, Alarcon JO, Siberry G, Weinberg A. Altered natural killerr cell function in HIV-exposed uninfected infants [Internet]. Frontiers in Immunology. 2017 ; 8[citado 2024 maio 13 ] Available from: https://doi.org/10.3389/fimmu.2017.00470
Artigo de periodico
Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits (2017)
Rossignoli, Matheus Teixeira; Lopes-Aguiar, Cleiton; Ruggiero, Rafael Naime; Silva, Raquel Araújo do Val; Bueno Júnior, Lezio Soares; Kandratavicius, Ludmyla; Peixoto-Santos, José Eduardo; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Szawka, Raphael Escorsim; Anselmo-Franci, Janete Aparecida; Leite, João Pereira; Romcy-Pereira, Rodrigo Neves
Fonte: Neuroscience. Unidades: FMRP, FORP
Assuntos: CANABINOIDES, CÓRTEX PRÉ-FRONTAL, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSIGNOLI, Matheus Teixeira et al. Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits. Neuroscience, v. 350, p. 85-93, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuroscience.2017.03.019. Acesso em: 13 maio 2024.
APA
Rossignoli, M. T., Lopes-Aguiar, C., Ruggiero, R. N., Silva, R. A. do V., Bueno Júnior, L. S., Kandratavicius, L., et al. (2017). Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits. Neuroscience, 350, 85-93. doi:10.1016/j.neuroscience.2017.03.019
NLM
Rossignoli MT, Lopes-Aguiar C, Ruggiero RN, Silva RA do V, Bueno Júnior LS, Kandratavicius L, Peixoto-Santos JE, Crippa JA de S, Hallak JEC, Zuardi AW, Szawka RE, Anselmo-Franci JA, Leite JP, Romcy-Pereira RN. Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits [Internet]. Neuroscience. 2017 ; 350 85-93.[citado 2024 maio 13 ] Available from: https://doi.org/10.1016/j.neuroscience.2017.03.019
Vancouver
Rossignoli MT, Lopes-Aguiar C, Ruggiero RN, Silva RA do V, Bueno Júnior LS, Kandratavicius L, Peixoto-Santos JE, Crippa JA de S, Hallak JEC, Zuardi AW, Szawka RE, Anselmo-Franci JA, Leite JP, Romcy-Pereira RN. Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: reduced dopaminergic modulation and immediate gene expression in limbic circuits [Internet]. Neuroscience. 2017 ; 350 85-93.[citado 2024 maio 13 ] Available from: https://doi.org/10.1016/j.neuroscience.2017.03.019
Artigo de periodico
Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice (2017)
Fonseca, Vanessa M. B; Milani, Thamires M. S; Prado, Rafael; Bonato, Vânia Luiza Deperon; Ramos, Simone G; Martins, Flaviano S; Vianna, Elcio dos Santos Oliveira; Borges, Marcos de Carvalho
Fonte: Respirology. Unidade: FMRP
Assuntos: SACCHAROMYCES, PROBIÓTICOS, MODELOS ANIMAIS, ASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Vanessa M. B et al. Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice. Respirology, v. 22, n. 5, p. 905-912, 2017Tradução . . Disponível em: https://doi.org/10.1111/resp.12990. Acesso em: 13 maio 2024.
APA
Fonseca, V. M. B., Milani, T. M. S., Prado, R., Bonato, V. L. D., Ramos, S. G., Martins, F. S., et al. (2017). Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice. Respirology, 22( 5), 905-912. doi:10.1111/resp.12990
NLM
Fonseca VMB, Milani TMS, Prado R, Bonato VLD, Ramos SG, Martins FS, Vianna E dos SO, Borges M de C. Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice [Internet]. Respirology. 2017 ; 22( 5): 905-912.[citado 2024 maio 13 ] Available from: https://doi.org/10.1111/resp.12990
Vancouver
Fonseca VMB, Milani TMS, Prado R, Bonato VLD, Ramos SG, Martins FS, Vianna E dos SO, Borges M de C. Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice [Internet]. Respirology. 2017 ; 22( 5): 905-912.[citado 2024 maio 13 ] Available from: https://doi.org/10.1111/resp.12990
Artigo de periodico
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey (2016)
Gobira, P. H.; Almeida-Santos, A. F.; Guimarães, Francisco Silveira; Moreira, F. A.; Aguiar, D. C.
Fonte: European Neuropsychopharmacology. Unidade: FMRP
Assuntos: CANABINOIDES, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL, TRANSTORNO DO PÂNICO, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOBIRA, P. H. et al. Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey. European Neuropsychopharmacology, v. 26, n. 1, p. 15-22, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2015.11.014. Acesso em: 13 maio 2024.
APA
Gobira, P. H., Almeida-Santos, A. F., Guimarães, F. S., Moreira, F. A., & Aguiar, D. C. (2016). Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey. European Neuropsychopharmacology, 26( 1), 15-22. doi:10.1016/j.euroneuro.2015.11.014
NLM
Gobira PH, Almeida-Santos AF, Guimarães FS, Moreira FA, Aguiar DC. Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey [Internet]. European Neuropsychopharmacology. 2016 ; 26( 1): 15-22.[citado 2024 maio 13 ] Available from: https://doi.org/10.1016/j.euroneuro.2015.11.014
Vancouver
Gobira PH, Almeida-Santos AF, Guimarães FS, Moreira FA, Aguiar DC. Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey [Internet]. European Neuropsychopharmacology. 2016 ; 26( 1): 15-22.[citado 2024 maio 13 ] Available from: https://doi.org/10.1016/j.euroneuro.2015.11.014
Artigo de periodico
Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions (2016)
Roy, Ashbeel; Dakroub, Mouhamed; Tezini, Geisa C. S. V.; Liu, Yin; Guatimosim, Silvia; Feng, Qingping; Salgado, Hélio César; Prado, Vania F.; Prado, Marco Antonio Maximo; Gros, Robert
Fonte: FASEB Journal. Unidade: FMRP
Assuntos: INSUFICIÊNCIA CARDÍACA, REMODELAÇÃO DAS VIAS AÉREAS, PROTEÍNAS DE TRANSPORTE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROY, Ashbeel et al. Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions. FASEB Journal, v. 30, n. 2, p. 688-701, 2016Tradução . . Disponível em: https://doi.org/10.1096/fj.15-277046. Acesso em: 13 maio 2024.
APA
Roy, A., Dakroub, M., Tezini, G. C. S. V., Liu, Y., Guatimosim, S., Feng, Q., et al. (2016). Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions. FASEB Journal, 30( 2), 688-701. doi:10.1096/fj.15-277046
NLM
Roy A, Dakroub M, Tezini GCSV, Liu Y, Guatimosim S, Feng Q, Salgado HC, Prado VF, Prado MAM, Gros R. Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions [Internet]. FASEB Journal. 2016 ; 30( 2): 688-701.[citado 2024 maio 13 ] Available from: https://doi.org/10.1096/fj.15-277046
Vancouver
Roy A, Dakroub M, Tezini GCSV, Liu Y, Guatimosim S, Feng Q, Salgado HC, Prado VF, Prado MAM, Gros R. Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions [Internet]. FASEB Journal. 2016 ; 30( 2): 688-701.[citado 2024 maio 13 ] Available from: https://doi.org/10.1096/fj.15-277046
Trabalho de evento-resumo periodico
Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma (2016)
Borges, Marcos de Carvalho; Fonseca, V. M.; Sandy, C.; Martins, F. S.; Vianna, Elcio dos Santos Oliveira
Fonte: American Journal of Respiratory and Critical Care Medicine. Nome do evento: American Thoracic Society International Conference (ATS). Unidade: FMRP
Assuntos: ASMA, MODELOS ANIMAIS DE DOENÇAS, CITOCINAS, SACCHAROMYCES, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Marcos de Carvalho et al. Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 13 maio 2024. , 2016
APA
Borges, M. de C., Fonseca, V. M., Sandy, C., Martins, F. S., & Vianna, E. dos S. O. (2016). Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Borges M de C, Fonseca VM, Sandy C, Martins FS, Vianna E dos SO. Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. 2016 ; 193[citado 2024 maio 13 ]
Vancouver
Borges M de C, Fonseca VM, Sandy C, Martins FS, Vianna E dos SO. Saccharomyces Cerevisiae Ufmg 905 modulates cytokine production in the cecum and inhibits lung inflammation in an animal model of asthma. American Journal of Respiratory and Critical Care Medicine. 2016 ; 193[citado 2024 maio 13 ]
Artigo de periodico
Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean (2016)
Spaulding, Alicen B.; Yu, Qilu; Civitello, Lucy; Mussi-Pinhata, Marisa Márcia; Pinto, Jorge; Gomes, Ivete M.; Alarcón, Jorge O.; Siberry, George K.; Harris, D. Robert; Hazra, Rohan
Fonte: AIDS Research and Human Retroviruses. Unidade: FMRP
Assuntos: CRIANÇAS, HIV, GRAVIDEZ, NEUROLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPAULDING, Alicen B. et al. Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean. AIDS Research and Human Retroviruses, v. 32, p. 349-356, 2016Tradução . . Disponível em: https://doi.org/10.1089/aid.2015.0254. Acesso em: 13 maio 2024.
APA
Spaulding, A. B., Yu, Q., Civitello, L., Mussi-Pinhata, M. M., Pinto, J., Gomes, I. M., et al. (2016). Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean. AIDS Research and Human Retroviruses, 32, 349-356. doi:10.1089/aid.2015.0254
NLM
Spaulding AB, Yu Q, Civitello L, Mussi-Pinhata MM, Pinto J, Gomes IM, Alarcón JO, Siberry GK, Harris DR, Hazra R. Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean [Internet]. AIDS Research and Human Retroviruses. 2016 ; 32 349-356.[citado 2024 maio 13 ] Available from: https://doi.org/10.1089/aid.2015.0254
Vancouver
Spaulding AB, Yu Q, Civitello L, Mussi-Pinhata MM, Pinto J, Gomes IM, Alarcón JO, Siberry GK, Harris DR, Hazra R. Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean [Internet]. AIDS Research and Human Retroviruses. 2016 ; 32 349-356.[citado 2024 maio 13 ] Available from: https://doi.org/10.1089/aid.2015.0254
Artigo de periodico
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies (2015)
Sanz, Miguel A.; Montesinos, Pau; Kim, Haesook T.; Ruiz-Argüelles, Guillermo J.; Undurraga, María S.; Uriarte, María R.; Martínez, Lem; Jacomo, Rafael H.; Gutiérrez-Aguirre, Homero; Melo, Raul A. M.; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia; Fagundes, Evandro M.; Vallenga, Edo; Holowiecka, Alexandra; González-Huerta, Ana J.; Fernández, Pascual; De La Serna, Javier; Brunet, Salut; De Lisa, Elena; González-Campos, José; Ribera, José M.; Krsnik, Isabel; Ganser, Arnold; Berliner, Nancy; Ribeiro, Raul C.; Lo-Coco, Francesco; Löwenberg, Bob; Rego, Eduardo Magalhães
Fonte: Annals of Hematology. Unidade: FMRP
Assuntos: LEUCEMIA, VITAMINA A, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANZ, Miguel A. et al. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, v. 94, n. 8, p. 1347-1356, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00277-015-2393-0. Acesso em: 13 maio 2024.
APA
Sanz, M. A., Montesinos, P., Kim, H. T., Ruiz-Argüelles, G. J., Undurraga, M. S., Uriarte, M. R., et al. (2015). All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, 94( 8), 1347-1356. doi:10.1007/s00277-015-2393-0
NLM
Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vallenga E, Holowiecka A, González-Huerta AJ, Fernández P, De La Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies [Internet]. Annals of Hematology. 2015 ; 94( 8): 1347-1356.[citado 2024 maio 13 ] Available from: https://doi.org/10.1007/s00277-015-2393-0
Vancouver
Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vallenga E, Holowiecka A, González-Huerta AJ, Fernández P, De La Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies [Internet]. Annals of Hematology. 2015 ; 94( 8): 1347-1356.[citado 2024 maio 13 ] Available from: https://doi.org/10.1007/s00277-015-2393-0
Artigo de periodico
Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation (2015)
Ferreira, Nathanne S.; Cau, Stefany B. A; Silva, Marcondes A. B.; Manzato, Carla Pavan; Mestriner, Fabiola Leslie Antunes Cardoso; Matsumoto, Takayuki; Carneiro, Fernando Silva; Passaglia, Rita de Cassia Aleixo Tostes
Fonte: Frontiers in Pharmacology. Unidade: FMRP
Assuntos: ALDOSTERONA, CÉLULAS ENDOTELIAIS, DIABETES MELLITUS, RECEPTORES HORMONAIS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Nathanne S. et al. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Frontiers in Pharmacology, v. 6, 2015Tradução . . Disponível em: https://doi.org/10.3389/fphar.2015.00034. Acesso em: 13 maio 2024.
APA
Ferreira, N. S., Cau, S. B. A., Silva, M. A. B., Manzato, C. P., Mestriner, F. L. A. C., Matsumoto, T., et al. (2015). Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Frontiers in Pharmacology, 6. doi:10.3389/fphar.2015.00034
NLM
Ferreira NS, Cau SBA, Silva MAB, Manzato CP, Mestriner FLAC, Matsumoto T, Carneiro FS, Passaglia R de CAT. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation [Internet]. Frontiers in Pharmacology. 2015 ; 6[citado 2024 maio 13 ] Available from: https://doi.org/10.3389/fphar.2015.00034
Vancouver
Ferreira NS, Cau SBA, Silva MAB, Manzato CP, Mestriner FLAC, Matsumoto T, Carneiro FS, Passaglia R de CAT. Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation [Internet]. Frontiers in Pharmacology. 2015 ; 6[citado 2024 maio 13 ] Available from: https://doi.org/10.3389/fphar.2015.00034

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos